| Name | Title | Contact Details |
|---|
Montoro and Associates Editorial Services is a Hoboken, NJ-based company in the Business Services sector.
Enviro Service Inc is a Needham, MA-based company in the Business Services sector.
Advisor provides expert services in operations, advisory and accounting for startups who require a solid roadmap and strategy to scale their business. A team of experienced CPAs, CFOs, Project Managers, Strategy Advisors, and Startup Specialists manage all your startup’s needs in Accounting, Human Resources, Payroll, Taxes, Compliance, Advisory, Fundraising, Valuations, M&A, Audit Prep and more. Most recently, the company has managed the audit prep and workflow for Twitter’s $350 million acquisition of MoPub. A long time client, MoPub began working with Advisor in 2011 soon after graduating from the AngelPad accelerator.
Axius Technology Inc was established in the year 2007 and has grown on fifty percent year-on-year in the terms of revenue and development as-well. Axius Tech expertise with various verticals such as, Energy and Utilities, Healthcare, Banking, Financial Services & Insurance, Retail, Axius technology maintain high professional standards and principles Uphold morals, ethics, and integrity in each of our procedures Create a work environment that nurtures camaraderie and growth Incessantly work towards more efficient, cost effective and quality services
Established in 2003 and headquartered in Boca Raton, Florida, RxStrategies, Inc. provides accountability, transparency and value-based solutions for the Federal 340B Drug Pricing Programs. As a full-service 340B Drug Pricing Program services organization, RxStrategies provides a diverse range of services to all “Qualified Entities” and the in-house and/or contract pharmacies, including 340B administration, split billing, orphan drug, and audit services. RxStrategies` “real-time” comprehensive solutions are designed to meet the challenges of regulatory compliance, patient eligibility, pharmacy replenishment, program tracking and reporting of the Federal 340B Drug Pricing Program.